Capital Fund Management (CFM)
BMY icon

Capital Fund Management (CFM)’s Bristol-Myers Squibb BMY Stock Holding History

Capital Fund Management (CFM)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.3M Sell
269,100
-543,900
-67% -$31.7M 0.07% 375
2025
Q4 		$43.9M Sell
813,000
-366,800
-31% -$17.6M 0.12% 210
2025
Q3 		$53.2M Sell
1,179,800
-16,300
-1% -$761K 0.14% 177
2025
Q2 		$55.4M Sell
1,196,100
-232,700
-16% -$11.4M 0.15% 183
2025
Q1 		$87.1M Buy
1,428,800
+138,900
+11% +$8.1M 0.25% 96
2024
Q4 		$73M Sell
1,289,900
-1,316,500
-51% -$73.6M 0.19% 151
2024
Q3 		$135M Sell
2,606,400
-1,393,800
-35% -$65.4M 0.37% 49
2024
Q2 		$166M Buy
4,000,200
+1,565,100
+64% +$70M 0.49% 15
2024
Q1 		$132M Sell
2,435,100
-560,100
-19% -$28.5M 0.38% 31
2023
Q4 		$154M Buy
2,995,200
+1,181,900
+65% +$62M 0.41% 29
2023
Q3 		$105M Buy
1,813,300
+1,030,000
+131% +$63.1M 0.36% 49
2023
Q2 		$50.1M Buy
783,300
+329,600
+73% +$22.1M 0.2% 123
2023
Q1 		$31.4M Sell
453,700
-207,800
-31% -$14.7M 0.15% 181
2022
Q4 		$47.6M Buy
661,500
+78,300
+13% +$5.9M 0.32% 66
2022
Q3 		$41.5M Buy
583,200
+219,900
+61% +$16M 0.33% 70
2022
Q2 		$28M Buy
363,300
+93,000
+34% +$7.08M 0.25% 87
2022
Q1 		$19.7M Buy
270,300
+88,600
+49% +$5.95M 0.16% 172
2021
Q4 		$11.3M Buy
181,700
+77,200
+74% +$4.53M 0.08% 335
2021
Q3 		$6.18M Buy
+104,500
New +$6.88M 0.05% 510
2021
Q2 		– Sell
-63,000
Closed -$3.98M – 1436
2021
Q1 		$3.98M Sell
63,000
-36,800
-37% -$2.29M 0.04% 495
2020
Q4 		$6.19M Sell
99,800
-331,100
-77% -$20.4M 0.06% 391
2020
Q3 		$26M Buy
430,900
+28,100
+7% +$1.69M 0.32% 85
2020
Q2 		$23.7M Sell
402,800
-602,400
-60% -$36M 0.38% 66
2020
Q1 		$56M Buy
1,005,200
+177,700
+21% +$10.9M 0.87% 9
2019
Q4 		$53.1M Buy
827,500
+456,900
+123% +$26.2M 0.42% 47
2019
Q3 		$18.8M Buy
370,600
+39,600
+12% +$1.86M 0.17% 165
2019
Q2 		$15M Sell
331,000
-17,300
-5% -$806K 0.14% 214
2019
Q1 		$16.6M Sell
348,300
-267,000
-43% -$13.3M 0.15% 193
2018
Q4 		$32M Sell
615,300
-234,700
-28% -$12.6M 0.28% 74
2018
Q3 		$52.8M Sell
850,000
-731,100
-46% -$43.4M 0.29% 59
2018
Q2 		$87.5M Buy
1,581,100
+1,512,600
+2,208% +$81.7M 0.46% 20
2018
Q1 		$4.33M Sell
68,500
-36,700
-35% -$2.36M 0.03% 739
2017
Q4 		$6.45M Sell
105,200
-33,100
-24% -$2.07M 0.04% 583
2017
Q3 		$8.81M Sell
138,300
-69,500
-33% -$4.06M 0.06% 366
2017
Q2 		$11.6M Sell
207,800
-443,600
-68% -$24.1M 0.09% 270
2017
Q1 		$35.4M Buy
651,400
+47,100
+8% +$2.58M 0.3% 86
2016
Q4 		$35.3M Buy
604,300
+94,500
+19% +$5.17M 0.3% 86
2016
Q3 		$27.5M Buy
509,800
+475,900
+1,404% +$30.6M 0.25% 100
2016
Q2 		$2.49M Sell
33,900
-14,200
-30% -$1M 0.02% 669
2016
Q1 		$3.07M Sell
48,100
-194,800
-80% -$12.3M 0.03% 569
2015
Q4 		$16.7M Buy
242,900
+84,300
+53% +$5.57M 0.17% 159
2015
Q3 		$9.39M Sell
158,600
-106,500
-40% -$6.76M 0.11% 253
2015
Q2 		$17.6M Buy
265,100
+64,600
+32% +$4.26M 0.22% 117
2015
Q1 		$12.9M Buy
200,500
+88,800
+79% +$5.56M 0.18% 151
2014
Q4 		$6.59M Buy
111,700
+4,300
+4% +$243K 0.08% 353
2014
Q3 		$5.5M Sell
107,400
-405,600
-79% -$20.3M 0.06% 390
2014
Q2 		$24.9M Buy
513,000
+246,100
+92% +$12.1M 0.26% 86
2014
Q1 		$13.9M Buy
266,900
+113,200
+74% +$6.02M 0.17% 129
2013
Q4 		$8.17M Buy
153,700
+28,000
+22% +$1.43M 0.1% 243
2013
Q3 		$5.82M Sell
125,700
-146,400
-54% -$6.43M 0.08% 323
2013
Q2 		$12.2M Buy
+272,100
New +$11.8M 0.19% 114

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Fund Management (CFM)'s BMY Position: Q1 2026 in Review

Capital Fund Management (CFM) reduced its Bristol-Myers Squibb (BMY) stake by 78% in Q1 2026, selling an estimated $49.2M and leaving 236,442 shares worth $14.3M. The position accounts for 0.06% of the portfolio, ranked #421.

Capital Fund Management (CFM) first reported a position in BMY in Q1 2014 and has held it in 34 quarters since. The position peaked at $98.8M in Q2 2018. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Capital Fund Management (CFM) held 236,442 shares of Bristol-Myers Squibb worth $14.3M as of Q1 2026.
  • Capital Fund Management (CFM) sold 844,824 Bristol-Myers Squibb shares in Q1 2026, an estimated $49.2M.
  • Bristol-Myers Squibb made up 0.06% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #421 holding.
  • Capital Fund Management (CFM) first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 34 quarters since.
  • Capital Fund Management (CFM)'s Bristol-Myers Squibb position peaked at $98.8M in Q2 2018.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.